Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06340620 · ClinicalTrials.gov registry record · NA
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
A NA study of Pancreatic Cancer and Gastrointestinal Cancer, sponsored by Orlando Health.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT06340620 is a NA study of Pancreatic Cancer and Gastrointestinal Cancer that is actively recruiting participants, run by Orlando Health. The registered enrollment target is 140 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06340620, a NA study of Pancreatic Cancer and Gastrointestinal Cancer, is actively recruiting participants, sponsored by Orlando Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.
Conditions Studied
Interventions
- DEVICE Endoscopic ultrasound examination
Study Locations (1)
Florida
- Orlando Health - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06340620
The ClinicalTrials.gov registry entry for NCT06340620 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (64% lower). The listed sponsor is Orlando Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic ultrasound examination is the first listed.
NCT06340620 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06340620 about?
NCT06340620 is a clinical study titled "EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope". This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.
What is the current status of trial NCT06340620?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2024-03-25. Estimated completion is 2027-12.
What conditions does trial NCT06340620 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Gastrointestinal Cancer, Pancreatic Cyst, Bile Duct Cancer, Pancreatic Disease.
What interventions are being tested in trial NCT06340620?
The interventions under investigation include: Endoscopic ultrasound examination (DEVICE).
Who is sponsoring clinical trial NCT06340620?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06340620 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
RECRUITING · NA
-
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
RECRUITING · NA
-
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
RECRUITING · NA
-
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.